This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, D.-K. Articles by Lee, W.-R. Search for Related Content PubMed PubMed Citation Articles by Kim, D.-K. Articles by Lee, W.-R.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3242-3247.)
© 1997 American Heart Association, Inc.

Articles

Polymorphism of Angiotensin Converting Enzyme Gene Is Associated With Circulating Levels of Plasminogen Activator Inhibitor-1

Duk-Kyung Kim; Jong-Won Kim; Seonwoo Kim; Hyeon-Cheol Gwon; Jae-Choon Ryu; Jeong-Eun Huh; Jin-A Choo; Youngran Choi; Chong-Heon Rhee; ; Won-Ro Lee

Correspondence to Won-Ro Lee, MD, PhD, Division of Cardiology, Department of Medicine, Samsung Medical Center, Sung Kyun Kwan University, College of Medicine, 50 Ilwon-dong, Kangnam-ku, Seoul 135–230, Korea. E-mail dkkim{at}smc.samsung.co.kr

Abstract The deletion (D) allele of the insertion/deletion (I/D) polymorphism of the angiotensin converting enzyme (ACE) gene is strongly associated with an increased level of circulating ACE. The ACE gene polymorphism may influence the production of angiotensin II (Ang II). It has been shown that Ang II modulates fibrinolysis, that is, Ang II increases plasminogen activator inhibitor-1 (PAI-1) mRNA and plasma PAI-1 levels in vitro and in vivo. Considered together, we tested the hypothesis that the deletion allele of the ACE gene might be associated with increased levels of PAI-1. We related the ACE genotype to PAI-1 antigen levels in 603 men and 221 women attending a routine health screening. As a whole, the plasma PAI-1 level was not strongly associated with ACE genotype. Since the PAI-1 level was significantly influenced by well-known risk factors for coronary artery disease (CAD), we further analyzed the data after excluding subjects with major cardiovascular risk factors. In low-risk male subjects, the DD genotype had significantly higher levels of plasma PAI-1 (DD: 20.3±2.2; DI: 13.9±1.1; II: 13.6±1.3 ng/mL, P=.010 by ANOVA). In low-risk female subjects, the DD genotype showed a tendency to a high level of plasma PAI-1 without statistical significance. When analysis was restricted to postmenopausal women (age55 or FSH35 ng/mL), the DD genotype showed a significantly higher level of PAI-1 than subjects with the DI and II genotypes (27.7±6.2 versus 15.6±1.8 ng/mL, P=.028). The DD polymorphism of the ACE gene is associated with high PAI-1 levels in male and possibly in postmenopausal female subjects who have lower conventional cardiovascular risk factors. These results suggest that the increased ACE activity caused by DD polymorphism may play an important role in elevating the level of plasma PAI-1. Our data support the notion that the genetic variation of ACE contributes to the balance of the fibrinolytic pathway.

Key Words: angiotensin converting enzyme • polymorphism • plasminogen activator inhibitor-1 • renin-angiotensin system

This article has been cited by other articles:

				V. Wiwanitkit Angiotensin-converting Enzyme Gene Polymorphism: I and D Alleles From Some Different Countries Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 179 - 182. [Abstract] [PDF]

				T. Buchholz, P. Lohse, N. Rogenhofer, E. Kosian, R. Pihusch, and C.J. Thaler Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages Hum. Reprod., November 1, 2003; 18(11): 2473 - 2477. [Abstract] [Full Text] [PDF]

				A. Prasad, S. Narayanan, M. A. Waclawiw, N. Epstein, and A. A. Quyyumi The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1579 - 1586. [Abstract] [Full Text] [PDF]

				D. C Felmeden and G. Y. Lip The renin-angiotensin-aldosterone system and fibrinolysis Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 240 - 244. [PDF]

				J. P.M Cleutjens, W.M. Blankesteijn, M. J.A.P Daemen, and J. F.M Smits The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions Cardiovasc Res, November 1, 1999; 44(2): 232 - 241. [Full Text] [PDF]

				B. T. Heijmans, R. G. J. Westendorp, D. L. Knook, C. Kluft, and P. E. Slagboom Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1176 - 1183. [Abstract] [Full Text] [PDF]

				N. J. Brown, M. A. Agirbasli, G. H. Williams, W. R. Litchfield, and D. E. Vaughan Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1 Hypertension, December 1, 1998; 32(6): 965 - 971. [Abstract] [Full Text] [PDF]